Clostridium difficile Toxin A Activators
The chemical class known as Clostridium difficile Toxin A Activators represents a group of compounds that play a crucial role in modulating the activity of the toxin A produced by the bacterium Clostridium difficile. Clostridium difficile is a Gram-positive, anaerobic bacterium that can cause gastrointestinal infections in humans, particularly in the colon. Toxin A is one of the major virulence factors produced by this bacterium and is responsible for the pathogenic effects associated with C. difficile infection. The activators in this chemical class are intricately involved in the activation or enhancement of the biological functions of Clostridium difficile Toxin A.
Structurally, Clostridium difficile Toxin A Activators exhibit specific molecular features that facilitate their interaction with Toxin A, ultimately influencing its activity. These compounds are thought to engage in complex molecular interactions with the toxin, potentially modulating its conformation or binding properties. Understanding the structural and biochemical details of these activators is essential for elucidating the mechanisms by which they influence Toxin A. This class of chemicals may serve as valuable tools for researchers studying the molecular pathways involved in C. difficile infections, offering insights into the intricate interplay between bacterial virulence factors and host cells. The exploration of Clostridium difficile Toxin A Activators contributes to the broader understanding of bacterial pathogenesis and provides targets for further research aimed at developing strategies to counteract the effects of C. difficile infections.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cytochalasin D | 22144-77-0 | sc-201442 sc-201442A | 1 mg 5 mg | $165.00 $486.00 | 64 | |
Cytochalasin D disrupts actin polymerization by binding to the growing end of F-actin, preventing further addition of actin monomers. Toxin A disrupts the actin cytoskeleton to exert its effects; hence, cytochalasin D can enhance this process by exacerbating actin cytoskeleton destabilization, indirectly enhancing Toxin A's pathogenic activity. | ||||||
Phalloidin | 17466-45-4 | sc-202763 | 1 mg | $234.00 | 33 | |
Phalloidin stabilizes F-actin polymers and prevents their disassembly. Toxin A causes depolymerization of F-actin; phalloidin can enhance the observable effects of Toxin A by initially stabilizing the actin filaments, which might lead to a more pronounced disruption once Toxin A exerts its action, indirectly amplifying the cytopathic effects of Toxin A. | ||||||
Jasplakinolide | 102396-24-7 | sc-202191 sc-202191A | 50 µg 100 µg | $184.00 $305.00 | 59 | |
Jasplakinolide stabilizes actin filaments and can lead to the formation of actin aggregates. When used in conjunction with Toxin A, it may enhance the Toxin A-induced disruption of the cytoskeleton by forming aggregates that are more difficult for the cell to resolve, potentially exacerbating the effects of Toxin A. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
Calcium ionophore A23187 increases intracellular calcium levels, which can influence various cellular processes, including those that Toxin A affects, such as vesicle trafficking and tight junction regulation. Elevated calcium levels can enhance Toxin A's effect on these processes, indirectly enhancing the toxin's pathogenic activity. | ||||||
PGE2 | 363-24-6 | sc-201225 sc-201225C sc-201225A sc-201225B | 1 mg 5 mg 10 mg 50 mg | $57.00 $159.00 $275.00 $678.00 | 37 | |
Prostaglandin E2 promotes inflammation and can enhance the inflammatory response initiated by Toxin A. It does so by upregulating inflammatory cytokines and mediators that may synergize with Toxin A's own pro-inflammatory effects, leading to an intensified inflammatory response, indirectly enhancing the functional activity of Toxin A. | ||||||
Lysophosphatidic Acid | 325465-93-8 | sc-201053 sc-201053A | 5 mg 25 mg | $98.00 $341.00 | 50 | |
LPA affects epithelial cell junction integrity and can modulate inflammatory responses. Through its action on cell junctions and inflammation, LPA can enhance the effects of Toxin A on these structures and processes, leading to increased epithelial permeability and inflammatory signaling, indirectly enhancing Toxin A's activity. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylyl cyclase, increasing cAMP levels in cells. Elevated cAMP may disrupt tight junctions and enhance chloride ion secretion in intestinal cells, which can amplify the effects of Toxin A on intestinal epithelial cells by promoting diarrhea and inflammation, indirect effects that enhance the functional activity of Toxin A. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin disrupts calcium homeostasis by inhibiting the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA). This can exacerbate the effects | ||||||